Continuous detection of proteins is crucial for health management and biomedical research. Electrochemical aptamer-based (E-AB) sensor that relies on binding affinity between a recognition oligonucleotide and its specific target is a versatile platform to fulfill this purpose. Yet, the vast majority of E-AB sensors are characterized by voltammetric methods, which suffer from signal drifts and low-frequency data acquisition during continuous operations. To overcome these limitations, we developed a novel E-AB sensor empowered by Gold nanoparticle-DNA Pendulum (GDP). Using chronoamperometric interrogation, the developed sensor enabled drift-resistant, high-frequency, and real-time monitoring of vascular endothelial growth factor (VEGF), a vital signaling protein that regulates angiogenesis, endothelial cell proliferation and vasculogenesis. We assembled VEGF aptamer-anchored GDP probes to a reduced graphene modified electrode, where a fast chronoamperometric current transient occurs as the GDP rapidly transport to the electrode surface. In the presence of target molecules, longer and concentration-dependent time decays were observed because of slower motion of the GDP in its bound state. After optimizing several decisive parameters, including composition ratios of GDP, probe density, and incubation time, the GDP empowered E-AB sensor achieves continuous, selective, and reversible monitoring of VEGF in both phosphate buffered saline (PBS) solutions and artificial urine with a wide detection range from 13 fM to 130 nM. Moreover, the developed sensor acquires signals on a millisecond timescale, and remains resistant to signal degradation during operation. This study offers a new approach to designing E-AB architectures for continuous biomolecular monitoring.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.talanta.2023.125026DOI Listing

Publication Analysis

Top Keywords

e-ab sensor
12
electrochemical aptamer-based
8
detection proteins
8
developed sensor
8
sensor
6
gdp
6
continuous
5
e-ab
5
pendulum-type electrochemical
4
aptamer-based sensor
4

Similar Publications

Article Synopsis
  • * One particular compound showed excellent performance with effective cross-linking, a stable electrochemical potential, and strong durability, making it ideal for sensor applications.
  • * The compound demonstrated consistent current levels in serum, effectively detecting doxorubicin, thus indicating its potential for developing reliable and sensitive sensors in clinical settings.
View Article and Find Full Text PDF

Carrion's disease, caused by infection with the bacterium (), is effectively treated with antibiotics, but reaches fatality rates of ~90% if untreated. Current diagnostic methods are limited, insufficiently sensitive, or require laboratory technology unavailable in endemic areas. Electrochemical aptamer-based (E-AB) biosensors provide a potential solution for this unmet need, as these biosensors are portable, sensitive, and can rapidly report the detection of small molecule targets.

View Article and Find Full Text PDF

Acute myocardial infarction (AMI) is one of the top contributors to global disease mortality. AMI biomarkers, such as cardiac troponin I (cTnI), are often detected with enzyme-linked immunosorbent assay (ELISA) that suffers from several well-known drawbacks such as poor stability and slow and cumbersome operation. Therefore, it is necessary to develop a new analytical technique that can rapidly analyse and detect cTnI for early screening of AMI.

View Article and Find Full Text PDF

Construction of an electrochemical aptamer-based sensors for rapid quantification of the anticancer drug imatinib in blood to improve drug bioavailability at microdoses.

Int J Biol Macromol

December 2024

Ministry of Education Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou 350116, China; Department of Anesthesiology, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China. Electronic address:

Imatinib (Ima), as a commonly used anticancer drug for the clinical treatment of leukemia and gastrointestinal mesenchymal stromal tumour, requires timely monitoring of patients' blood concentration to ensure efficacy while reducing complications and achieving precision medicine due to its narrow therapeutic window (1-5 μM) and the varying sensitivity and resistance of different patients to Ima. However, traditional assays are slow and cumbersome, so improved and innovative platforms for monitoring Ima in the clinic are necessary. In this work, a nanoporous electrochemical aptamer-based (E-AB) sensor was designed for the detection of Ima and imatinib mesylate (Ima-Mes) in blood.

View Article and Find Full Text PDF
Article Synopsis
  • Traditional RT-qPCR for SARS-CoV-2 detection is highly sensitive but slow and labor-intensive, limiting its use in community screenings.
  • A new electrochemical aptamer-based biosensor (E-AB) was developed to target the SARS-CoV-2 nucleocapsid protein, achieving rapid results within 5 minutes.
  • The biosensor demonstrated high specificity and effectiveness in detecting the N protein in artificial saliva, paving the way for quicker and more accessible saliva-based diagnostics.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!